Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Short-term Investments: 2015-2024

Historic Short-term Investments for CorMedix (CRMD) over the last 8 years, with Dec 2024 value amounting to $11.0 million.

  • CorMedix's Short-term Investments fell 24.69% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 24.69%. This contributed to the annual value of $11.0 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Short-term Investments stood at $11.0 million for FY2024, which was down 29.45% from $15.6 million recorded in FY2022.
  • Over the past 5 years, CorMedix's Short-term Investments peaked at $15.6 million during FY2022, and registered a low of $4.4 million during FY2020.
  • Moreover, its 2-year median value for Short-term Investments was $13.3 million (2022), whereas its average is $13.3 million.
  • In the last 5 years, CorMedix's Short-term Investments plummeted by 62.92% in 2020 and then soared by 173.38% in 2021.
  • Yearly analysis of 4 years shows CorMedix's Short-term Investments stood at $4.4 million in 2020, then soared by 173.38% to $12.1 million in 2021, then climbed by 28.77% to $15.6 million in 2022, then reached $11.0 million in 2024.